Brief: Zevra Therapeutics Reports First Quarter 2023 Results

Zevra Therapeutics

15/05/2023 22:53

May 15 (Reuters) - Zevra Therapeutics Inc  ZVRA.O :
    * ZEVRA THERAPEUTICS REPORTS CORPORATE UPDATES AND FIRST
QUARTER
2023 FINANCIAL RESULTS
    * ZEVRA THERAPEUTICS - CHRISTAL MICKLE, CO-FOUNDER & CHIEF
DEVELOPMENT OFFICER, APPOINTED TO SERVE AS INTERIM PRESIDENT AND
CEO EFFECTIVE JUNE 1, 2023
    * AS OF MARCH 31, 2023, TOTAL CASH, CASH EQUIVALENTS, AND
INVESTMENTS WERE $95.3 MILLION
    * ZEVRA-BASED ON CO'S CURRENT OPERATING FORECAST,EXISTING
CASH,CASH EQUIVALENTS,INVESTMENTS EXPECTED TO BE SUFFICIENT TO
CONTINUE OPERATIONS INTO 2026
    * QTRLY LOSS PER SHARE $0.34
    * Q1 EARNINGS PER SHARE VIEW $-0.23 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nGNX74MLRF 
Further company coverage:  ZVRA.O 

 ((Reuters.Briefs@thomsonreuters.com;))